Request Deal Involvement

China Life Private Equity Investment led a $79m Series A round in Huisheng Biopharmaceutical.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Ernst & Young

accounting advisors

Ernst & Young

or

Principals

SIHUAN PHARMACEUTICAL

vendor

SIHUAN PHARMACEUTICAL

TIANJIN GRAND FLIGHT

bidder

TIANJIN GRAND FLIGHT

HUISHENG BIOPHARMACEUTICAL

target

HUISHENG BIOPHARMACEUTICAL

CHINA LIFE PRIVATE EQUITY INVESTMENT

bidder

CHINA LIFE PRIVATE EQUITY INVESTMENT

GINKGO CAPITAL

bidder

GINKGO CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - China Life Private Equity Investment led a $79m Series A round in Huisheng Biopharmaceutical.